Perspectives and experiences with COVID-19 vaccines in people with MS.

John R Ciotti Dana C Perantie Brandon P Moss Kathryn C Fitzgerald Jeffrey A CohenEllen M MowryRobert T NaismithSalim Chahin

Published in: Multiple sclerosis journal - experimental, translational and clinical (2022)

Most individuals with MS surveyed plan to receive the COVID-19 vaccine. People with MS experience similar side effects to the general population, and few experience transient MS symptom worsening. These results can inform conversations on vaccination between providers and people with MS.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
coronavirus disease
sars cov
respiratory syndrome coronavirus
subarachnoid hemorrhage